ASCO 2015 Report — Gastrointestinal Cancer

At this year's annual meeting of the American Society of Clinical Oncology (ASCO 2015), held May 29 through June 2 in Chicago, specialists discussed the latest findings in cancer research. The editors of NEJM Journal Watch Oncology and Hematology were in attendance to report highlights of the conference. Here, Associate Editor David Ilson, MD, reviews key presentations on new gastrointestinal cancer treatments. All meeting abstracts can be viewed in the ASCO meeting library).

DNA Mismatch Repair Status Predictive of Immunotherapy Benefit in Colorectal Cancer

One of the most important presentations was the demonstration of potential efficacy for immunotherapy in a subset of patients with metastatic colorectal cancer (CRC). Prior trials of anti…